Skip to main content
. 2020 May 9;10(5):740. doi: 10.3390/biom10050740

Table 1.

Listing of inhibitors and antagonists used in the study. This table described different inhibitors and antagonists used for experiments. Concentrations and reference were also noticed.

Compounds Name Target Concentration Reference
CGS15943 Adenosine receptors antagonist 1 µM Avanzato et al. [24]
SCH442416 selective receptor antagonist A2A 10 µM Yu et al. [25]
MRS1754 selective receptor antagonist A2B 0.1 µM Salie et al. [26]
MRS1191 selective receptor antagonist A3 10 µM Salie et al. [26]
LY294002 PI3K inhibitor 10 µM Urban et al. [27]
5-HD mitoKATP inhibitor 100 µM Millart et al. [28]
L-NAME NOS inhibitor 10 µM Millart et al. [28]
indomethacin COX inhibitor 5 µM Alm et al. [29]